US Patent 11325902 Benzenesulfonamide compounds and their use as therapeutic agents
Patent 11325902 was granted and assigned to Xenon Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Alla Yurevna Zenova0
Kristen Nicole Burford0
Michael Scott Wilson0
Thilo Focken0
Verner Alexander Lofstrand0
Edits on 3 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 3 Apr, 2023
Golden AI
Infobox
Edits on 27 Sep, 2022
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113259020
Date of Patent
May 10, 2022
0Patent Application Number
169271780
Date Filed
July 13, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 23 Sep, 2022
Golden AI
Infobox
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+341 characters)
US Patent 11325902 Benzenesulfonamide compounds and their use as therapeutic agents
Article
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11325902
Date of patent
May 10, 2022
Patent application number
16927178
Date Filed
July 13, 2020
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11325902 Benzenesulfonamide compounds and their use as therapeutic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
